In 2023, sales of obstructive airway diseases medicine in Italy were recorded at 28.5 US Dollars PPP Per Capita. Forecasts predict a steady growth from 2024, with values reaching up to 30.6 by 2028. Year-on-year analysis indicates a gradual sales increase, showing consistent annual growth. The Compound Annual Growth Rate (CAGR) for the five-year forecast period is approximately 1.5%.

Future trends to watch for include:

The potential impact of new therapeutic developments and approvals on the market.
Changes in demographic factors, such as aging population, affecting demand.
Healthcare policy updates in Italy that might influence drug accessibility and pricing.